Search

Gabriele Neumann

age ~60

from Madison, WI

Also known as:
  • Gabriela Neumann

Gabriele Neumann Phones & Addresses

  • Madison, WI
  • Nanuet, NY

Us Patents

  • Recombinant Influenza Vectors With Tandem Transcription Units

    view source
  • US Patent:
    7968101, Jun 28, 2011
  • Filed:
    Nov 18, 2005
  • Appl. No.:
    11/283498
  • Inventors:
    Yoshihiro Kawaoka - Middleton WI, US
    Gabriele Neumann - Madison WI, US
  • Assignee:
    Wisconsin Alumni Research Foundation - Madison WI
  • International Classification:
    A01N 63/00
    A61K 39/00
    A61K 39/12
    A61K 39/145
    A61K 45/00
    C12Q 1/70
    C12P 1/00
    C12P 19/34
    C12N 7/02
    C12N 15/00
    C12N 15/74
    A61K 39/285
  • US Classification:
    4242061, 4241841, 4242041, 4242051, 4242091, 424 936, 424 932, 4242811, 435 5, 435 41, 435 9133, 435239, 4353201, 435476, 435489
  • Abstract:
    The invention provides a composition useful to prepare influenza viruses, e. g. , in the absence of helper virus, using vectors which include tandem transcription cassettes containing PolI and/or PolII promoters.
  • Cell-Based Systems For Producing Influenza Vaccines

    view source
  • US Patent:
    8163523, Apr 24, 2012
  • Filed:
    Jun 9, 2009
  • Appl. No.:
    12/481402
  • Inventors:
    Pamuk Bilsel - Madison WI, US
    Yoshihiro Kawaoka - Middleton WI, US
    Gabriele Neumann - Madison WI, US
  • Assignee:
    Flugen, Inc. - Madison WI
  • International Classification:
    C12P 19/34
  • US Classification:
    435 911, 435358, 435325, 4242091
  • Abstract:
    The present invention relates to a cell-based method for producing influenza virus vaccines by enriching the population of surface-bound α2,6-sialic acid receptors on a cell surface, such as on a Chinese Hamster Ovary (CHO) cell surface. The host cell therefore presents numerous binding sites to which an influenza virus can bind via its hemagglutinin spike protein and infect the host cell. In contrast to wild-type CHO cells, the surface of the mutated CHO cells of the present invention contains an enriched population of α2,6-sialic acid receptors which makes the inventive CHO cells highly susceptible to viral infection, and therefore safe, effective, and highly efficient cells for rapidly producing influenza vaccines.
  • Recombinant Influenza Viruses For Vaccines And Gene Therapy

    view source
  • US Patent:
    20030035814, Feb 20, 2003
  • Filed:
    Oct 4, 2001
  • Appl. No.:
    09/971372
  • Inventors:
    Yoshihiro Kawaoka - Middleton WI, US
    Gabriele Neumann - Nanuet NY, US
  • International Classification:
    A61K039/21
    C12N007/00
  • US Classification:
    424/208100, 435/235100
  • Abstract:
    The invention provides a composition useful to prepare influenza A viruses, e.g., in the absence of helper virus.
  • Filovirus Vectors And Noninfectious Filovirus-Based Particles

    view source
  • US Patent:
    20030215794, Nov 20, 2003
  • Filed:
    Jan 29, 2003
  • Appl. No.:
    10/353856
  • Inventors:
    Yoshihiro Kawaoka - Madison WI, US
    Luke Jasenosky - Madison WI, US
    Gabriele Neumann - Madison WI, US
  • International Classification:
    C12Q001/70
    C12N007/00
    C12N007/02
    C12N001/18
    C12N005/06
    C07K014/01
  • US Classification:
    435/005000, 435/235100, 435/239000, 435/325000, 435/348000, 435/254200, 530/395000, 435/456000
  • Abstract:
    Cloned filovirus genomic cDNA and methods of using the cDNA are provided. Further provided are noninfectious lipid encapsulated filovirus-based particles.
  • Recombinant Influenza Viruses For Vaccines And Gene Therapy

    view source
  • US Patent:
    20060057116, Mar 16, 2006
  • Filed:
    Jun 10, 2005
  • Appl. No.:
    11/150631
  • Inventors:
    Yoshihiro Kawaoka - Middleton WI, US
    Gabriele Neumann - Nanuet NY, US
  • International Classification:
    A61K 48/00
    C12N 5/08
    C12N 15/86
  • US Classification:
    424093200, 435456000, 435366000
  • Abstract:
    The invention provides a composition useful to prepare influenza A viruses, e.g., in the absence of helper virus.
  • Recombinant Influenza Viruses For Vaccines And Gene Therapy

    view source
  • US Patent:
    20060134138, Jun 22, 2006
  • Filed:
    Apr 20, 2005
  • Appl. No.:
    11/110117
  • Inventors:
    Yoshihiro Kawaoka - Middleton WI, US
    Gabriele Neumann - Nanuet NY, US
  • International Classification:
    A61K 39/145
    C12N 5/06
    C12N 15/86
  • US Classification:
    424209100, 435456000, 435325000, 435349000
  • Abstract:
    The invention provides a composition useful to prepare influenza A viruses, e.g., in the absence of helper virus.
  • Screening Method For Modulators Of Viral Transcription Or Replication

    view source
  • US Patent:
    20090017444, Jan 15, 2009
  • Filed:
    Jun 7, 2007
  • Appl. No.:
    11/810956
  • Inventors:
    Yoshihiro Kawaoka - Middleton WI, US
    Gabriele Neumann - Madison WI, US
  • Assignee:
    WISCONSIN ALUMNI RESEARCH FOUNDATION - MADISON WI
  • International Classification:
    C12Q 1/70
  • US Classification:
    435 5
  • Abstract:
    The invention provides methods to identify modulators of viral transcription or replication.
  • Recombinant Influenza Viruses For Vaccines And Gene Therapy

    view source
  • US Patent:
    20090246830, Oct 1, 2009
  • Filed:
    Jan 7, 2009
  • Appl. No.:
    12/349769
  • Inventors:
    Yoshihiro KAWAOKA - Middleton WI, US
    Gabriele Neumann - Nanuet NY, US
  • Assignee:
    Wisconsin Alumni Research Foundation - Madison WI
  • International Classification:
    C12P 21/02
  • US Classification:
    435 693
  • Abstract:
    A method for producing influenza virus particles for preparation of a vaccine. The method comprises growing reassortant influenza viruses to produce virus particles and recovering the produced virus particles. The reassortant influenza viruses are produced in cultured cells in the absence of helper virus by introducing into the cultured cells expression vectors sufficient to produce genomic vRNA or antigenomic vRNA (cRNA) segments in the cells of reassortant influenza viruses. The method produces a nucleoprotein and an RNA dependent RNA polymerase in the cells so that RNP complexes containing the genomic vRNA segments of the reassortant influenza viruses are formed. The method uses expression vectors containing HA, NA, non-HA and non-NA vRNA segments in which the HA and NA vRNA segments are HA and NA vRNA segments of a viral strain different from a strain that contains all of the non-HA and non-NA vRNA segments.

Youtube

JS Bach - Cantata "Wir Mssen durch viel Trbsa...

For Jubilate (Third Sunday after Easter). Poet unknown. 12 May 1726 or...

  • Category:
    Music
  • Uploaded:
    12 Dec, 2009
  • Duration:
    6m 50s

Gabriele van Hees - Denn die Liebe kommt von ...

Auszge mit Bildern aus dem Buch "Denn die Liebe kommt von Gott" von Ga...

  • Category:
    Entertainment
  • Uploaded:
    30 Dec, 2009
  • Duration:
    6m 46s

10.06.2010: Plenum Kompakt vom Donnerstag

Zusammenschnitt aus dem Plenum des Deutschen Bundestages vom Donnersta...

  • Category:
    News & Politics
  • Uploaded:
    10 Jun, 2010
  • Duration:
    20m 1s

16.12.2010 - Plenum Kompakt vom Donnerstag

Plenum Kompakt mit folgenden Rednern: Rainer Stinner, Elke Hoff (1.30)...

  • Category:
    News & Politics
  • Uploaded:
    17 Dec, 2010
  • Duration:
    15m 28s

17.06.2010 - Plenum Kompakt vom Donnerstag

Zusammenschnitt aus dem Plenum vom Donnerstag den 17.06.2010 mit folge...

  • Category:
    News & Politics
  • Uploaded:
    17 Jun, 2010
  • Duration:
    16m 42s

Meine Zukunft: Gabriele Neumann-Beiler zu 50 ...

Unsere Videoserie zum 50. Geburtstag des Nationalparks Bayerischer Wal...

  • Duration:
    55s

Gabriel Neumann, Fiasco Alumni, chats about 6...

Learn how you can support Fiasco Theater at fiascotheater.co...

  • Duration:
    1m 48s

Hatchimals arlarm

  • Duration:
    2m 33s

Googleplus

Gabriele Neumann Photo 1

Gabriele Neumann

Facebook

Gabriele Neumann Photo 2

Gabriele Neumann

view source
Friends:
Priscila Neumann, Debora da Silva, Patricia Medina Gonalves
Gabriele Neumann Photo 3

Gabriele Neumann

view source
Gabriele Neumann Photo 4

Gabriele Neumann

view source
Friends:
Babette Courtois, Detlef Stahl
Gabriele Neumann Photo 5

Gabriele Neumann

view source
Gabriele Neumann Photo 6

Gabriele Neumann

view source
Gabriele Neumann Photo 7

Gabriele Neumann

view source
Gabriele Neumann Photo 8

Gabriele Neumann

view source
Gabriele Neumann Photo 9

Gabriele Neumann

view source
Facebook ermglicht den Menschen das Teilen von Inhalten mit anderen und vernetzt ...

News

Bharat Biotech To Develop Intranasal Coronavirus Vaccine

Bharat Biotech to develop intranasal coronavirus vaccine

view source
  • CoroFlu will build on the backbone of FluGens flu vaccine candidate known as M2SR. Based on an invention by UW-Madison virologists and FluGen co-founders Yoshihiro Kawaoka and Gabriele Neumann, M2SR is a self-limiting version of the influenza virus that induces an immune response against the flu.
  • Date: Apr 05, 2020
  • Category: More news
  • Source: Google
Flu Déjà Vu

Flu Déjà Vu

view source
  • Yet another tactic is in the works at FluGen, a biotech spinoff that uses technology initially developed in the labs of Yoshihiro Kawaoka and Gabriele Neumann at the University of Wisconsin-Madison. The premise of the companys RedeeFlu vaccineis that it takes a naturally occurring flu virus and mo
  • Date: Mar 14, 2018
  • Category: Health
  • Source: Google
Get Ready, Some Medical Experts Are Predicting The Worst Flu Season In History

Get ready, some medical experts are predicting the worst flu season in history

view source
  • Yoshihiro Kawaoka and Dr. Gabriele Neumann and exclusively licensed to FluGen. "Our vaccine, called RedeeFlu, is based on a premise that says, what happens if you take a [naturally occurring] 'wild-type' of flu virus and modify it to infect the human body but don't allow it to replicate and cause i
  • Date: Jan 09, 2018
  • Category: Health
  • Source: Google

Get Report for Gabriele Neumann from Madison, WI, age ~60
Control profile